Tempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services to analytic and cloud-and-compute tools to pharmaceutical and biotechnology companies; and Trials that provides clinical trial matching services to pharmaceutical companies. In addition, it operates Next; Algos, a suite of algorithmic tests in oncology; Hub, a desktop and mobile platform for ordering, managing, and receiving tests and patient results; and Lens, a platform for researchers and scientists to find, access, and analyze Tempus data. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.

Tempus AI Inc.

Tempest Minerals Limited ( ($AU:TEM) ) has provided an update. Tempest Minerals has exited the Elephant Project joint venture, ending all current a...

Tempest Minerals Exits Elephant JV to Refocus on Core Projects

In a report released today, Charles Minervino from Susquehanna maintained a Hold rating on Stem Inc, with a price target of $10.00. Minervino cover...

Susquehanna Keeps Their Hold Rating on Stem Inc (STEM)

SThree plc ( ($GB:STEM) ) just unveiled an update. SThree plc has repurchased a total of its own ordinary shares on the London Stock Exchange betwe...

SThree Reduces Share Capital with Latest Buyback on London Market

Cathie Wood’s ARK Invest&nbsp;ETFs&nbsp;(exchange-traded funds) made surprising portfolio adjustments on Thursday, March 26, as shown in ARK’s dail...

Cathie Wood Rotates $84M Out of Meta, Nvidia, Chip Stocks – Here’s Why

GF Securities analyst maintained a Buy rating on Tongcheng Travel Holdings Limited yesterday and set a price target of HK$24.14. In a report releas...

Tongcheng Travel Holdings Limited (0780) Receives a Buy from GF Securities

In a report released yesterday, from Huatai Securities maintained a Buy rating on Tongcheng Travel Holdings Limited, with a price target of HK$29.9...

Tongcheng Travel Holdings Limited (0780) Gets a Buy from Huatai Securities

In a report released yesterday, from Goldman Sachs maintained a Buy rating on Tongcheng Travel Holdings Limited, with a price target of HK$29.00. I...

Goldman Sachs Remains a Buy on Tongcheng Travel Holdings Limited (0780)

In a report released today, Patricia Yeung from DBS maintained a Buy rating on Tongcheng Travel Holdings Limited, with a price target of HK$26.50. ...

DBS Keeps Their Buy Rating on Tongcheng Travel Holdings Limited (0780)

Tongcheng Travel Holdings Limited ( ($HK:0780) ) just unveiled an announcement. Tongcheng Travel Holdings reported solid top-line growth for the fo...

Tongcheng Travel Delivers Q4 Revenue and Adjusted Profit Growth Despite Decline in Reported Earnings

Berenberg Bank analyst initiated coverage with a Buy rating on Temenos yesterday and set a price target of CHF95.00. The company’s shares closed la...

Temenos (TMNSF) Initiated with a Buy at Berenberg Bank

An announcement from SThree plc ( ($GB:STEM) ) is now available. SThree plc disclosed that its Employees’ Share Ownership Plan Trust has acquired 8...

SThree Expands Employee Share Trust with £1.49m Share Purchase

PERSOL HOLDINGS CO ( ($JP:2181) ) has issued an update. Persol Holdings has outlined the strategic direction of its Career SBU in an analyst briefi...

Persol shifts Career SBU to AI-driven model after doda integration hit

An announcement from SThree plc ( ($GB:STEM) ) is now available. SThree plc disclosed that Chief Financial Officer Andrew Beach acquired 87 partner...

SThree Executives Acquire Shares Under Incentive and Global Employee Plans

Cathie Wood’s ARK Invest ETFs (exchange-traded funds) made several notable portfolio moves on Thursday, March 12, according to the firm’s daily tra...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	TEM	$44.16	0.00%	5.72M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	TEM	$44.16	0%	5.72M
3
4
5
6

TEM

TEM

Get Tempus AI Inc. Data in Excel

Get Tempus AI Inc. Data in Excel